265 related articles for article (PubMed ID: 17896305)
1. Comparison of survival among eligible patients not enrolled versus enrolled in the Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma.
Gilson MM; Diener-West M; Hawkins BS
Ophthalmic Epidemiol; 2007; 14(4):251-7. PubMed ID: 17896305
[TBL] [Abstract][Full Text] [Related]
2. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma: IV. Ten-year mortality findings and prognostic factors. COMS report number 24.
Hawkins BS;
Am J Ophthalmol; 2004 Dec; 138(6):936-51. PubMed ID: 15629284
[TBL] [Abstract][Full Text] [Related]
3. Ten-year follow-up of fellow eyes of patients enrolled in Collaborative Ocular Melanoma Study randomized trials: COMS report no. 22.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2004 May; 111(5):966-76. PubMed ID: 15121376
[TBL] [Abstract][Full Text] [Related]
4. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma II: initial mortality findings. COMS report no. 10.
Am J Ophthalmol; 1998 Jun; 125(6):779-96. PubMed ID: 9645716
[TBL] [Abstract][Full Text] [Related]
5. The Collaborative Ocular Melanoma Study (COMS) randomized trial of pre-enucleation radiation of large choroidal melanoma I: characteristics of patients enrolled and not enrolled. COMS report no. 9.
Am J Ophthalmol; 1998 Jun; 125(6):767-78. PubMed ID: 9645715
[TBL] [Abstract][Full Text] [Related]
6. Collaborative ocular melanoma study randomized trial of I-125 brachytherapy.
Hawkins BS
Clin Trials; 2011 Oct; 8(5):661-73. PubMed ID: 22013172
[TBL] [Abstract][Full Text] [Related]
7. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
8. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
9. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, II: characteristics of patients enrolled and not enrolled. COMS Report No. 17.
Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
Arch Ophthalmol; 2001 Jul; 119(7):951-65. PubMed ID: 11448318
[TBL] [Abstract][Full Text] [Related]
10. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma, III: initial mortality findings. COMS Report No. 18.
Diener-West M; Earle JD; Fine SL; Hawkins BS; Moy CS; Reynolds SM; Schachat AP; Straatsma BR;
Arch Ophthalmol; 2001 Jul; 119(7):969-82. PubMed ID: 11448319
[TBL] [Abstract][Full Text] [Related]
11. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2002 Dec; 109(12):2197-206. PubMed ID: 12466159
[TBL] [Abstract][Full Text] [Related]
12. Trends in size and treatment of recently diagnosed choroidal melanoma, 1987-1997: findings from patients examined at collaborative ocular melanoma study (COMS) centers: COMS report no. 20.
Collaborative Ocular Melanoma Study Group
Arch Ophthalmol; 2003 Aug; 121(8):1156-62. PubMed ID: 12912694
[TBL] [Abstract][Full Text] [Related]
13. Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3.
Melia M; Moy CS; Reynolds SM; Hayman JA; Murray TG; Hovland KR; Earle JD; Kurinij N; Dong LM; Miskala PH; Fountain C; Cella D; Mangione CM;
Arch Ophthalmol; 2006 Feb; 124(2):226-38. PubMed ID: 16476893
[TBL] [Abstract][Full Text] [Related]
14. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
15. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain.
Correa R; Pera J; Gómez J; Polo A; Gutiérrez C; Caminal JM; Modolell I; Navarro V; Guedea F
Brachytherapy; 2009; 8(3):290-6. PubMed ID: 19428308
[TBL] [Abstract][Full Text] [Related]
16. Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy.
Augsburger JJ; Corrêa ZM; Freire J; Brady LW
Ophthalmology; 1998 Sep; 105(9):1670-8. PubMed ID: 9754176
[TBL] [Abstract][Full Text] [Related]
17. The COMS Randomized Trial of Iodine 125 Brachytherapy for Choroidal Melanoma: IV. Local Treatment Failure and Enucleation in the First 5 Years after Brachytherapy. COMS Report No. 19.
Jampol LM; Moy CS; Murray TG; Reynolds SM; Albert DM; Schachat AP; Diddie KR; Engstrom RE; Finger PT; Hovland KR; Joffe L; Olsen KR; Wells CG;
Ophthalmology; 2020 Apr; 127(4S):S148-S157. PubMed ID: 32200815
[TBL] [Abstract][Full Text] [Related]
18. The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.
Collaborative Ocular Melanoma Study Group
Arch Ophthalmol; 2006 Dec; 124(12):1684-93. PubMed ID: 17159027
[TBL] [Abstract][Full Text] [Related]
19. Mortality after deferral of treatment or no treatment for choroidal melanoma.
Straatsma BR; Diener-West M; Caldwell R; Engstrom RE;
Am J Ophthalmol; 2003 Jul; 136(1):47-54. PubMed ID: 12834669
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
